Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
3.980
+0.080 (2.05%)
At close: Jun 18, 2026, 4:00 PM EDT
3.820
-0.160 (-4.02%)
After-hours: Jun 18, 2026, 4:10 PM EDT
Molecular Partners AG Employees
Molecular Partners AG had 134 employees as of December 31, 2025. The number of employees decreased by 25 or -15.46% compared to the previous year.
Employees
134
Change (1Y)
-25
Growth (1Y)
-15.46%
Revenue / Employee
n/a
Profits / Employee
-$539,838
Market Cap
143.54M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 134 | -25 | -15.46% |
| Dec 31, 2024 | 159 | -9 | -5.37% |
| Dec 31, 2023 | 168 | -8 | -4.45% |
| Dec 31, 2022 | 175 | 12 | 7.41% |
| Dec 31, 2021 | 163 | 18 | 12.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 187 |
| Tenaya Therapeutics | 70 |
| Korro Bio | 49 |
| Corbus Pharmaceuticals Holdings | 36 |
| Enlivex | 34 |
| Spero Therapeutics | 25 |
| TuHURA Biosciences | 22 |
| Tiziana Life Sciences | 10 |
MOLN News
- 19 days ago - Molecular Partners to hold trial-in-progress presentations on Phase 1/2a study - TheFly
- 20 days ago - Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1 - GlobeNewsWire
- 23 days ago - Molecular Partners AG at TD Cowen Oncology Innovation Summit (Virtual) Transcript - GuruFocus
- 23 days ago - Molecular Partners AG Transcript: 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - Transcripts
- 24 days ago - Molecular Partners to Present at TD Cowen's 7th Annual Oncology Innovation Summit - GlobeNewsWire
- 5 weeks ago - Molecular Partners Reports Financial Results and Highlights for Q1 2026, with Clinical Studies Initiated on MP0712 and MP0317 - GlobeNewsWire
- 5 weeks ago - Molecular Partners AG Earnings release: Q1 2026 - Filings
- 5 weeks ago - Molecular Partners AG Slides: Corporate presentation - Filings